FSD Pharma Inc. | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 05/31/2024 at 13:30, 10 months 13 days ago

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
FSD Pharma Inc. confirms arbitration awards against former CEO Dr. Raza Bokhari. United States District Court grants final judgment for monetary damages. Company focuses on biopharmaceutical solutions for neurodegenerative disorders

FSD Pharma Inc. Arbitration Awards Neurodegenerative Disorders United States District Court Biopharmaceutical Solutions
BRIEF

published on 05/28/2024 at 14:05, 10 months 16 days ago

FSD Pharma soumet un protocole d'essai clinique pour Unbuzzd™ dans le traitement de l'intoxication alcoolique aiguë

FSD Pharma Essai Clinique Unbuzzd™ Intoxication Alcoolique Essai METAL-2
BRIEF

published on 05/28/2024 at 14:05, 10 months 16 days ago

FSD Pharma Submits Clinical Trial Protocol for Unbuzzd™ in Acute Alcohol Intoxication

FSD Pharma Clinical Trial Unbuzzd™ Alcohol Intoxication METAL-2 Trial
PRESS RELEASE

published on 05/28/2024 at 14:00, 10 months 16 days ago

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached

FSD Pharma Unbuzzd(TM) Alcohol Intoxication Clinical Trial Protocol Dr. Andrzej Chruscinski
BRIEF

published on 05/24/2024 at 20:39, 10 months 19 days ago

FSD Pharma annonce un accord de relations avec les investisseurs avec IR Agency LLC

Biopharmaceutique FSD Pharma Relations Avec Les Investisseurs Agence RI Psychéeutiques Lucides
BRIEF

published on 05/24/2024 at 20:39, 10 months 19 days ago

FSD Pharma Announces Investor Relations Agreement with IR Agency LLC

Investor Relations FSD Pharma Biopharmaceutical IR Agency Lucid Psycheceuticals
PRESS RELEASE

published on 05/24/2024 at 20:34, 10 months 19 days ago

FSD Pharma Provides Corporate Update
FSD Pharma Inc. enters investor relations services agreement with IR Agency LLC, focusing on communicating information to the financial community. Company building innovative biotech solutions

Investor Relations FSD Pharma Inc. Biopharmaceutical Innovative Assets IR Agency LLC
BRIEF

published on 05/16/2024 at 14:05, 10 months 28 days ago

FSD Pharma Announces New Packaging for Unbuzzd™ Beverage

FSD Pharma Beverage Industry Unbuzzd New Packaging Responsible Drinking
BRIEF

published on 05/16/2024 at 14:05, 10 months 28 days ago

FSD Pharma annonce un nouvel emballage pour la boisson Unbuzzd™

FSD Pharma L'industrie Des Boissons Consommation Responsable Unbuzzd Nouvel Emballage
PRESS RELEASE

published on 05/16/2024 at 14:00, 10 months 28 days ago

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
FSD Pharma Inc. announces new packaging and logo for unbuzzd™ beverage product in collaboration with Celly Nutrition Corp. and Six+One, set to launch this summer, targeting alcohol metabolizing and promoting alertness

FSD Pharma Inc. Celly Nutrition Corp. Unbuzzd Six+One Packaging Logo

Accesswire

Published on 04/12/2025 at 15:45, 1 day 3 hours ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 17 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 19 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 19 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 19 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 21 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 2 days ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 2 days ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 2 days 1 hour ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 2 days ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days 1 hour ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days 1 hour ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days 1 hour ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE